EC Number |
Inhibitors |
Structure |
---|
2.7.7.64 | EDTA |
- |
|
2.7.7.64 | EDTA |
complete inhibition |
|
2.7.7.64 | ethyl 2,4-dimethyl-5-[(2R)-2-[4-(2-phenoxyethyl)piperazin-1-yl]propanoyl]-1H-pyrrole-3-carboxylate |
- |
|
2.7.7.64 | hydrogen peroxide |
inactivation, reactivation by reduction using cysteine or thioredoxin |
|
2.7.7.64 | methyl (2R)-2-[[2-(4-fluorophenyl)sulfanylacetyl]amino]-3-hydroxypropanoate |
- |
|
2.7.7.64 | methyl(3-fluorophenyl)acetate |
- |
|
2.7.7.64 | more |
identification of structurally diverse scaffolds for the development of USP inhibitors by fragment library screening, selection of small molecule inhibitors with allosteric regulation sites, that inhibit both Leishmania major USP and UGP. Inhibitor binding kinetics, computational docking study, overview |
|
2.7.7.64 | N-(2-methoxyethyl)-2-oxo-1,3-benzoxazole-3(2H)-carboxamide |
- |
|
2.7.7.64 | nitric oxide |
inactivation, reactivation by reduction using cysteine or thioredoxin |
|